Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • Français
  • my CNW 
    • Login
    • Register
  • Client Login 
    • PR Newswire Amplify™
    • Next Gen Communications Cloud
    • Cision Communications Cloud®
  • Sign Up
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
Advanced Search
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Canadian Federal Government
      • Canadian Municipal Government
      • Canadian Provincial Government
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

  • Advanced Search
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • IR
  • All Products
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Hamburger menu
  • Cision Canada
  • Send a Release
  • FR
    • Phone

    • 877-269-7890 from 8 AM - 10 PM ET

    • ALL CONTACT INFO
    • Contact Cision

      877-269-7890
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • IR
  • All Products
  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR
  • Sign Up
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media Enquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR

Strategic Expansion: Laboratoire Suisse and Cosmetic Import Continue Their Growth with the Acquisition of Les Laboratoires Colba's Assets Français

JAMP Pharma Group (CNW Group/Corporation JAMP Pharma)

News provided by

Corporation JAMP Pharma

Dec 02, 2025, 09:24 ET

Share this article

Share toX

Share this article

Share toX

BOUCHERVILLE, QC, Dec. 2, 2025 /CNW/ - The JAMP Pharma Group, a Canadian leader in the pharmaceutical sector, announced today that its over-the-counter natural health and cosmetic products division, through its subsidiaries Laboratoire Suisse Inc. and Cosmetic Import Ltd, is acquiring the assets of Les Laboratoires Colba Inc., including the Racine de Vie®, Alpen Secrets®, and Blue ShimmerTM brands.

Well-established in Quebec since 1983, Laboratoires Colba manufactures quality natural health and cosmetic products distributed across Canada. Les Laboratoires Colba, Laboratoire Suisse, and Cosmetic Import share a fundamental common value: A commitment to the quality and excellence of their respective products. They also strive to offer them at a fair and competitive price, thus ensuring excellent value for Canadian consumers.

An Expanded Portfolio for a More Comprehensive Offering

In addition to ensuring the continuity of the Racine de Vie®, Alpen Secrets®, and Blue ShimmerTM brands, which are firmly established in the Canadian market, this acquisition will strategically consolidate the position of Laboratoire Suisse and Cosmetic Import by deepening their natural health product offering and diversifying their cosmetic product range.

A Local Acquisition and Distribution Opportunities

Laboratoires Colba is delighted to see its brands, created and marketed in Canada for several years, being taken over by Laboratoire Suisse and Cosmetic Import. Both organizations are not only Quebec-based and operate locally, but they have also chosen to acquire the assets of a local company.

This acquisition will ensure the continuity and development of the production of a portion of our natural health product line in Quebec, from our state-of-the-art facilities in Lévis.

Through this strategic acquisition, Laboratoire Suisse and Cosmetic Import will also be able to:

  • Access new distribution channels across the country.
  • Solidify their Canadian presence, strengthening their role as a national leader in the sector.

« The acquisition of the emblematic brands of Laboratoires Colba, a local company, is a source of immense pride and a strategic vision that perfectly aligns with our DNA. Taking over the legacy of these Quebec brands is a strong move that reiterates our unwavering commitment to Quebec's economic development. Above all, it is a significant business opportunity that will support our growth and contribute to value creation for the local economy. » declares Louis Pilon, President and CEO of JAMP Pharma Group.

«This transaction represents a perfect synergy of values and expertise, » explains Guylaine Thériault Rehel, General Manager, WSC. «The acquisition of these emblematic Quebec brands is a transformative step for our division. It allows us not only to significantly broaden our offering but, above all, to consolidate our presence and leadership across the entire Canadian market. We are proud to integrate a brand heritage so appreciated by Canadians. »

« We are very pleased that an esteemed Quebec company has chosen to maintain the brands Laboratoires Colba has developed over 40 years in Quebec. We would like to thank our team, our employees, our representatives, and our director for all these years of loyalty and remarkable work, » emphasizes Jean-Paul Bassili, President of Laboratoires Colba.

About the JAMP Pharma Group's Over-the-Counter Products Division

Our division brings together three emblematic entities: Laboratoire Suisse inc., Wampole, and Cosmetic Import Ltd.

Since 1989, Laboratoire Suisse inc., initially a family business, has offered a complete range of natural health products. Over 75% of its products are now manufactured in Quebec, reflecting a strong commitment to quality and local economic vitality. The mission is clear: to combine science and nature to support the well-being of Quebecers through a product offering for digestion, sleep, energy, and immune health.

Wampole, the first natural health product company established in Canada in 1893, is now a nationally recognized guarantee of quality. Its commitment remains to provide high-quality, science-backed natural health products, as it continues to push boundaries, offering a complete range of products for all ages and needs. Its recent line expansion, with the launch of its new children's body care line under the Adorable by Wampole brand, demonstrates its passion for offering quality products for the whole family, now extending to bath time.

Founded in 1956, Cosmetic Import Ltd has become an essential reference in the world of skincare and cosmetics in Canada. The company is proud to offer bath, body, and hair products, including iconic brands such as Algemarin, French Formula, and Henri Bernard Crystal Minéral, designed to simply integrate into the daily routines of Canadians, bringing well-being and simplicity.

Together, these three entities offer a diversified portfolio of high-quality health and care brands and products, all rooted in a tradition of excellence and a strong local commitment.

About the JAMP Pharma Group 

The JAMP Pharma Group is a Canadian organization based in Boucherville, in the greater Montreal area. Having experienced exceptional growth over the last 10 years, the JAMP Pharma Group is present in all segments of the pharmaceutical market and now has the most extensive range of generic drugs in Canada*, with nearly 350 molecules.

This leadership in the generic drug sector significantly reinforces our long-term vision and our commitment to the health of Canadians. By increasing access to affordable, high-quality therapeutic options, we play a vital role in improving healthcare for all. Moreover, our portfolio represents substantial savings for the country's public and private healthcare systems, freeing up resources for other essential needs.

In addition to its generic division, the JAMP Pharma Group has several divisions such as Orimed, BioJAMP, JAMP Acute Care and Injectables, Wampole, Laboratoire Suisse, and Cosmetic Import, also offering prescription and branded products, biosimilar products, 180 over-the-counter products with a varied range of vitamins,

supplements, and natural health products. The JAMP Care™ Patient Support Program is designed to assist patients, as well as healthcare professionals, in taking specialty medications and biosimilars offered by JAMP Pharma Group. Since 2024,

The JAMP Pharma Group also owns its own manufacturing site, located in Lévis. This site supports the continuous accessibility of quality medications and healthcare solutions for Canadians. By doing so, we elevate our level of service for community pharmacies and hospitals, enabling them in turn to offer optimal service and continuity of care to their patients.

*Based on the number of distinct molecules and dosage forms actively marketed and generating revenue greater than $0, as reported in a data source commonly used in the pharmaceutical industry between April 1, 2024, and March 31, 2025.

www.labsuisse.com 

www.healthandbeautycare.ca 

www.jamppharma.ca 

SOURCE Corporation JAMP Pharma

Information: Guylaine Thériault Rehel, General Manager, Wampole, Laboratoires Suisse et Cosmetic Import, 514-209-2448, [email protected]

Modal title

Organization Profile

Corporation JAMP Pharma

    Also from this source

  • JAMP Pharma Group launches PrPexegra® (pegfilgrastim) and PrFilra® (filgrastim), two new biosimilar therapeutic options in oncology

Contact Cision

  • 866-245-2317
    from 8 AM - 10 PM ET
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media

Products

  • Cision Communications Cloud®
  • Media Monitoring
  • Content Distribution
  • Multimedia Distribution
  • Measurement & Analytics
  • Investor Relations

About

  • About Cision Canada
  • About Cision
  • Media Partners
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Platform Login
  • Next Gen Communications Cloud
  • Cision Communications Cloud®
  • my CNW
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Platform
  • Next Gen Communications Cloud
  • Cision Communications Cloud
  • my CNW
877-269-7890
from 8 AM - 10 PM ET
  • Terms of Use
  • Information Security Policy
  • Site Map
  • Cookie Settings
  • Accessibility Statement
Copyright © 2025 CNW Group Ltd. All Rights Reserved. A Cision company.